Author: Woolhouse I, Bishop L, Darlison L, De Fonseka D, Edey A, Edwards J, Faivre-Finn C, Fennell DA, Holmes S, Kerr KM, Nakas A, Peel T, Rahman NM, Slade M, Steele J, Tsim S, Maskell NA
Year: 2018
AGREE II score: Available
Developer organization: British Thoracic Society
Type of cancer: Lung
Patient population: Adult
Location: International
This is a clinical practice guideline for patients with malignant pleural mesothelioma (MPM). The guideline provides recommendations on the investigation of suspected MPM, and the subsequent care and management of individuals with proven MPM. Topics of interest include the preferred investigation pathway of suspected cases of MPM, biomarkers, and the role of different treatments including chemotherapy.
AGREE II - Quality of Reporting Assessment:
Scope and purpose: 88.9%
Applicability: 39.6%
Stakeholder involvement: 80.6%
Editorial independence: 83.3%
Rigour: 75%
Clarity presentation: 88.9%
